These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1069 related articles for article (PubMed ID: 27354052)
21. Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomised trials. Haller PM; Vargas KG; Haller MC; Piackova E; Wojta J; Gyöngyösi M; Gersh BJ; Kiss A; Podesser BK; Huber K Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(1_suppl):82-92. PubMed ID: 29911392 [TBL] [Abstract][Full Text] [Related]
22. Clinical translation of myocardial conditioning. Bøtker HE; Lassen TR; Jespersen NR Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1225-H1252. PubMed ID: 29498531 [TBL] [Abstract][Full Text] [Related]
23. Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Hausenloy DJ; Garcia-Dorado D; Bøtker HE; Davidson SM; Downey J; Engel FB; Jennings R; Lecour S; Leor J; Madonna R; Ovize M; Perrino C; Prunier F; Schulz R; Sluijter JPG; Van Laake LW; Vinten-Johansen J; Yellon DM; Ytrehus K; Heusch G; Ferdinandy P Cardiovasc Res; 2017 May; 113(6):564-585. PubMed ID: 28453734 [TBL] [Abstract][Full Text] [Related]
25. Cardioprotection: chances and challenges of its translation to the clinic. Heusch G Lancet; 2013 Jan; 381(9861):166-75. PubMed ID: 23095318 [TBL] [Abstract][Full Text] [Related]
26. Impact of postconditioning with lactate-enriched blood on in-hospital outcomes of patients with ST-segment elevation myocardial infarction. Koyama T; Munakata M; Akima T; Kageyama T; Shibata M; Moritani K; Kanki H; Ishikawa S; Mitamura H Int J Cardiol; 2016 Oct; 220():146-8. PubMed ID: 27379916 [TBL] [Abstract][Full Text] [Related]
27. Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype? Lønborg JT Heart; 2015 Oct; 101(20):1612-8. PubMed ID: 26130664 [TBL] [Abstract][Full Text] [Related]
28. Platelet inhibition to target reperfusion injury trial: Rationale and study design. Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441 [TBL] [Abstract][Full Text] [Related]
29. Meta-Analysis of Randomized Trials on Remote Ischemic Conditioning During Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. Elbadawi A; Ha LD; Abuzaid AS; Crimi G; Azzouz MS Am J Cardiol; 2017 Mar; 119(6):832-838. PubMed ID: 28065491 [TBL] [Abstract][Full Text] [Related]
30. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Freixa X; Bellera N; Ortiz-Pérez JT; Jiménez M; Paré C; Bosch X; De Caralt TM; Betriu A; Masotti M Eur Heart J; 2012 Jan; 33(1):103-12. PubMed ID: 21846677 [TBL] [Abstract][Full Text] [Related]
31. Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome. Rossello X; Lobo-Gonzalez M; Ibanez B Eur Heart J Acute Cardiovasc Care; 2019 Aug; 8(5):443-456. PubMed ID: 31172789 [TBL] [Abstract][Full Text] [Related]
32. Can Clinical and Functional Outcomes Be Improved with an Intelligent "Internet Plus"-Based Full Disease Cycle Remote Ischemic Conditioning Program in Acute ST-elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention? Rationale and Design of the i-RIC Trial. Zheng Y; Reinhardt JD; Li J; Hu D; Lin S; Wang L; Dai R; Fan Z; Ding R; Chen L; Yuan L; Xu Z; Cheng Y; Yan C; Zhang X; Wang L; Zhang X; Teng M; Yu Q; Yin A; Lu X; Cardiovasc Drugs Ther; 2022 Feb; 36(1):45-57. PubMed ID: 32607820 [TBL] [Abstract][Full Text] [Related]
33. Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial. Yetgin T; van Kranenburg M; Ten Cate T; Duncker DJ; de Boer MJ; Diletti R; van Geuns RM; Zijlstra F; Manintveld OC Catheter Cardiovasc Interv; 2016 Oct; 88(4):508-514. PubMed ID: 27022882 [TBL] [Abstract][Full Text] [Related]
34. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets. Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214 [TBL] [Abstract][Full Text] [Related]
35. Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope. He J; Bellenger NG; Ludman AJ; Shore AC; Strain WD Rev Cardiovasc Med; 2022 Jan; 23(1):23. PubMed ID: 35092215 [TBL] [Abstract][Full Text] [Related]
37. [Advance in the study of myocardial ischemic preconditioning and postconditioning and the clinical applications]. Wu YJ; Fang LH; Du GH Yao Xue Xue Bao; 2013 Jul; 48(7):965-70. PubMed ID: 24133962 [TBL] [Abstract][Full Text] [Related]
38. Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning. Skyschally A; Walter B; Heusch G Eur Heart J; 2013 Nov; 34(42):3314-21. PubMed ID: 23242190 [TBL] [Abstract][Full Text] [Related]
39. Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Hahn JY; Song YB; Kim EK; Yu CW; Bae JW; Chung WY; Choi SH; Choi JH; Bae JH; An KJ; Park JS; Oh JH; Kim SW; Hwang JY; Ryu JK; Park HS; Lim DS; Gwon HC Circulation; 2013 Oct; 128(17):1889-96. PubMed ID: 24068776 [TBL] [Abstract][Full Text] [Related]